Spark Therapeutics, Inc. (ONCE)

[TheFinalCD]

fitty bucks!!!

[crudeoil24]

49.99 hod so far!

[MONEYMADE]

"first-ever FDA approval for a gene therapy product."


That could do it!

[crudeoil24]

This has the potential to be $500.+ by end of year. Float appears to be 1M
shares. Company controls shares. First ever FDA gene therapy approval product in a matter of a few months. DAT'S WHAT I'M TALKIN 'BOUT.

[KingDMC]

Break 48.90 and it's off to $50

[KingDMC]

Awesome. $55 by Monday now I'll take that bet!

[crudeoil24]

The buzz around ONCE stemmed in part from its potential to receive the first-ever FDA approval for a gene therapy product.

[crudeoil24]

I say we close @ $55.+

[KingDMC]

Yeah tell me about it. I'm all out there. Riding this train.

[crudeoil24]

Shake Shack is Not the Only IPO Making Some Noise -- Market Talk
1 hours 3 minutes ago - DJNF

11:55 EST - Shake Shack (SHAK) may be hogging the spotlight today by jumping more than 130% in its stock-trading debut, but another IPO is also making a splash. Spark Therapeutics (ONCE) priced its IPO last night at $23 a share, above its range of $19 to $21--a range that already had been raised. The gene therapy company, whose first product candidate targets rare blinding conditions, also sold more shares than expected (7M vs. its original plan to offer 5.5M shares). The buzz around ONCE stemmed in part from its potential to receive the first-ever FDA approval for a gene therapy product, according to one fund manager. ONCE shares opened at $45.10, 96% above their IPO price. They're recently traded at $42.14. ([e-mail])
(END) Dow Jones Newswires

January 30, 2015 11:55 ET (16:55 GMT)

[crudeoil24]

More confident in this than the flaming SHAK burger...lol

[KingDMC]

$46 approaching!

[crudeoil24]

LOL....I wish they were my buys. Looking for more info on this company. May buy more shares later today near close.

[crudeoil24]

Same here..... I have a few @ 42.34

[KingDMC]

Should have known it would bounce I saw several 50k and 60k blocks on the bid heavy around $42. That's what made me buy at 40.50

[KingDMC]

Really kicking myself for not doubling down uughhh

[crudeoil24]

Folks loading up! 44.08

[crudeoil24]

FDA phase III info on: http://www.sparktx.com

[KingDMC]

Good I'll hold. Should have doubled down I saw mid 40's not long ago

[crudeoil24]

Possibly! >>> has a ONE MILLION FLOAT >> IT CAN MOVE FAST!

[KingDMC]

Think it'll get back up there? Bounced off that low $40 pretty hard.

[crudeoil24]

ONCE opened @ 45.10

[crudeoil24]

5,500,000 shares @ $15 - 17 Managers: JPMorgan, Credit Suisse Spark's most advanced product candidate is currently in Phase 3 clinical trials with results expected in the second half of 2015. The product has received both breakthrough therapy designation and orphan product designation, meaning preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies and qualifies for certain development incentives. The fast-track status has gained the interest of the buyside and the deal is already well oversubscribed.

[crudeoil24]

BIG DAY TODAY >>>> IPO.